Key Recommendations from the 2023 Guidelines for Managing Atopic Dermatitis (AD)

Share the knowledge

  1. Topical Treatments:
  • Use topical corticosteroids (TCS) or topical calcineurin inhibitors (TCIs) for patients whose AD remains uncontrolled despite regular use of moisturizers.
  • Crisaborole 2% ointment is suggested for mild-to-moderate AD.
  1. Bleach Baths:
  • Recommended as an add-on therapy for patients with moderate-to-severe AD, but not advised for those with mild AD.
  1. Elimination Diets:
  • Not generally recommended due to unclear benefits and potential risks.
  1. Systemic Treatments:
  • Biologics like dupilumab and tralokinumab are advised for moderate-to-severe AD.
  • Oral JAK inhibitors may be considered in refractory cases, with careful patient selection.

References

  • Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations [link]

Share the knowledge
Leave a Reply 0